This HTML5 document contains 106 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n12	http://dx.doi.org/10.1200/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q52863875

rdf:type

wikibase:Item

schema:description

scientific article published in August 2000 vitenskapelig artikkel artículu científicu আগস্ট ২০০০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2000년 논문 bài báo khoa học scientific article published in August 2000 scienca artikolo مقالة علمية نشرت في أغسطس 2000 vedecký článok 2000年学术文章 επιστημονικό άρθρο научна статия videnskabelig artikel 2000年学术文章 artículo científico publicado en 2000 teaduslik artikkel 2000年學術文章 artigo científico vitskapeleg artikkel 2000年学术文章 wetenschappelijk artikel artigo científico наукова стаття, опублікована в серпні 2000 vetenskaplig artikel articolo scientifico 2000年学术文章 2000年の論文 scientific article published in August 2000 article científic 2000 nî lūn-bûn artikull shkencor научная статья artykuł naukowy 2000年學術文章 article scientifique vědecký článek мақолаи илмӣ artigo científico 2000年學術文章 სამეცნიერო სტატია article scientific научни чланак tieteellinen artikkeli articol științific 2000年学术文章 bilimsel makale научни чланак 2000年學術文章 naučni članak מאמר מדעי wissenschaftlicher Artikel บทความทางวิทยาศาสตร์ tudományos cikk artikulong pang-agham artikel ilmiah 2000年学术文章 2000年學術文章

p:P577

wds:Q52863875-D66E24BC-D3BA-410F-930C-75E81CE0046D

wdt:P577

2000-08-01T00:00:00Z

p:P407

wds:Q52863875-34309629-AD10-40F7-83AB-DC590B89F6DC

wdt:P407

wd:Q1860

p:P2093

wds:Q52863875-426C4A09-3242-4516-B8CD-07518595C7C0 wds:Q52863875-A50017D8-2BB3-4E5D-A2DB-C4549DCFD49A wds:Q52863875-D1094576-60F3-4868-BA8A-FC4F7B64C9DA wds:Q52863875-D1D6A114-74D6-4C1B-AC51-11FAA63A375E wds:Q52863875-ECD5BE5C-4F6B-4D8E-9C32-7D1643F9D6F6

wdt:P2093

M Drayson S J Rollinson E Roman F E Davies J A Child

rdfs:label

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.

skos:prefLabel

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.

schema:name

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.

p:P50

wds:Q52863875-C2AED847-2171-47B7-837C-4FDB1E90556C wds:Q52863875-E50EC0E4-9223-43E9-83BB-8CBD889D933E wds:Q52863875-3C0165DE-910C-467D-AA7E-075FF12A39DA

wdt:P50

wd:Q61996585 wd:Q38544276 wd:Q63126590

p:P1476

wds:Q52863875-B81CE29F-5B12-4169-8E51-AD4B6795AA1B

wdt:P1476

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment

p:P304

wds:Q52863875-2D025795-22BA-4B4B-B6ED-08BA9C1A023A

wdt:P304

2843-2851

p:P31

wds:Q52863875-98A2A643-139B-4600-A250-FB2DDE405DD7

wdt:P31

wd:Q13442814

p:P698

wds:Q52863875-7F98F2DF-7432-4A06-AE65-0CFF8B9CA423

wdtn:P698

n11:10920132

wdt:P698

10920132

p:P1433

wds:Q52863875-467141D2-009B-4B10-8B6C-BD1FAB0145BC

wdt:P1433

wd:Q400292

p:P433

wds:Q52863875-356DE0CC-BFC6-46F3-8E24-4A722F516AEA

p:P478

wds:Q52863875-80087560-C9F3-472A-A7E4-7E4AA6BCF2E8

wdt:P433

15

wdt:P478

18

p:P356

wds:Q52863875-5CAE69C6-B6FD-4AB7-A1B4-29BEA5C7C7CA

wdtn:P356

n12:JCO.2000.18.15.2843

wdt:P356

10.1200/JCO.2000.18.15.2843